C.R. Bard (BCR): $8.6 million was the positive money flow into the stock on Tuesday and the up/down ratio of ticks was also in favor of the bulls at 1.3. The value of trades done on upticks was $37.58 million, whereas, trades done on downticks were valued at $28.98 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $7.98 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $7.98 million. C.R. Bard (BCR) fell $1.6 traded at $235.57, a change of -0.67% over the previous day. The stock is -1.44% for the week.
The company Insiders own 0.97% of C.R. Bard shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -6.25% . Institutional Investors own 93.02% of C.R. Bard shares. During last six month period, the net percent change held by insiders has seen a change of -14.77%. In an insider trading activity, Holland Christopher S, officer (Senior Vice President and CFO) of Bard C R Inc /Nj/, unloaded 3,970 shares at an average price of $219.88 on May 27, 2016. The total amount of the transaction was worth $872,924, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
CR Bard Inc. has dropped 0.58% in the last five trading days, however, the shares have posted positive gains of 4.53% in the last 4 weeks. CR Bard Inc. is up 15.13% in the last 3-month period. Year-to-Date the stock performance stands at 24.66%.
C.R. Bard (NYSE:BCR): On Tuesdays trading session , Opening price of the stock was $237.63 with an intraday high of $237.87. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $235.31. However, the stock managed to close at $235.57, a loss of 0.67% for the day. On the previous day, the stock had closed at $237.17. The total traded volume of the day was 562,890 shares.
C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.